<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0021141" disease_type="Disease or Syndrome" abbrv="SIADH">syndrome of inappropriate antidiuretic hormone secretion</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SIADH</z:e>) is frequently responsible for <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002902'>hyponatremia</z:hpo> in the elderly due to age-related disruption of the inhibitory component of brain osmoregulatory mechanisms </plain></SENT>
<SENT sid="1" pm="."><plain>Recent research has indicated that <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002902'>hyponatremia</z:hpo> is associated with <z:hpo ids='HP_0001288'>gait disturbances</z:hpo>, increased <z:hpo ids='HP_0002527'>falls</z:hpo>, and <z:hpo ids='HP_0002659'>bone fragility</z:hpo> in humans, and we have found that <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002902'>hyponatremia</z:hpo> causes <z:hpo ids='HP_0002797'>increased bone resorption</z:hpo> and <z:hpo ids='HP_0004349'>reduced bone mineral density</z:hpo> in young rats </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we used a model of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SIADH</z:e> to study multi-organ consequences of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002902'>hyponatremia</z:hpo> in aged rats </plain></SENT>
<SENT sid="3" pm="."><plain>Sustained <z:hpo ids='HP_0002902'>hyponatremia</z:hpo> for 18 weeks caused progressive reduction of bone mineral density by DXA and decreased bone ash calcium, phosphate and <z:chebi fb="199" ids="26708">sodium</z:chebi> contents at the tibia and lumbar vertebrae </plain></SENT>
<SENT sid="4" pm="."><plain>Administration of 10-fold higher <z:chebi fb="27" ids="27300">vitamin D</z:chebi> during the last 8 weeks of the study compensated for the reduction in bone formation and halted bone loss </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0857122" disease_type="Disease or Syndrome" abbrv="">Hyponatremic</z:e> rats developed <z:hpo ids='HP_0000135'>hypogonadism</z:hpo>, as indicated by slightly lower serum <z:chebi fb="51" ids="17347">testosterone</z:chebi> and higher serum FSH and LH concentrations, markedly decreased testicular weight, and abnormal testicular histology </plain></SENT>
<SENT sid="6" pm="."><plain>Aged <z:e sem="disease" ids="C0857122" disease_type="Disease or Syndrome" abbrv="">hyponatremic</z:e> rats also manifested decreased body fat, skeletal muscle sarcopenia by densitometry, and <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> manifested as <z:mp ids='MP_0002833'>increased heart weight</z:mp> and perivascular and interstitial <z:mp ids='MP_0003045'>fibrosis</z:mp> by histology </plain></SENT>
<SENT sid="7" pm="."><plain>These findings are consistent with recent results in cultured osteoclastic cells, indicating that low extracellular <z:chebi fb="199" ids="26708">sodium</z:chebi> concentrations increased <z:mp ids='MP_0003674'>oxidative stress</z:mp>, thereby potentially exacerbating multiple manifestations of senescence </plain></SENT>
<SENT sid="8" pm="."><plain>Future prospective studies in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SIADH</z:e> may indicate whether these multi-organ age-related comorbidities may potentially contribute to the observed increased incidence of fractures and mortality in this population </plain></SENT>
</text></document>